Page last updated: 2024-10-24

chelerythrine and Parkinson Disease

chelerythrine has been researched along with Parkinson Disease in 1 studies

chelerythrine : A benzophenanthridine alkaloid isolated from the root of Zanthoxylum simulans, Chelidonium majus L., and other Papaveraceae.

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Nguyen, DT1
Iqbal, J1
Han, J1
Pierens, GK1
Wood, SA1
Mellick, GD1
Feng, Y1

Other Studies

1 other study available for chelerythrine and Parkinson Disease

ArticleYear
Chemical constituents from Macleaya cordata (Willd) R. Br. and their phenotypic functions against a Parkinson's disease patient-derived cell line.
    Bioorganic & medicinal chemistry, 2020, 11-01, Volume: 28, Issue:21

    Topics: Alkaloids; Cell Line; Circular Dichroism; Density Functional Theory; Humans; Lysosomes; Magnetic Res

2020